- Home
- KNSA vs GDV Comparison
KNSA vs GDV Comparison
Compare KNSA & GDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KNSA
- GDV
- Stock Information
- Founded
- KNSA 2015
- GDV 2003
- Country
- KNSA United Kingdom
- GDV United States
- Employees
- KNSA N/A
- GDV N/A
- Industry
- KNSA Biotechnology: Pharmaceutical Preparations
- GDV Investment Managers
- Sector
- KNSA Health Care
- GDV Finance
- Exchange
- KNSA Nasdaq
- GDV Nasdaq
- Market Cap
- KNSA 2.1B
- GDV 2.2B
- IPO Year
- KNSA 2018
- GDV N/A
- Fundamental
- Price
- KNSA $27.12
- GDV $26.37
- Analyst Decision
- KNSA Strong Buy
- GDV
- Analyst Count
- KNSA 6
- GDV 0
- Target Price
- KNSA $39.33
- GDV N/A
- AVG Volume (30 Days)
- KNSA 980.0K
- GDV 186.0K
- Earning Date
- KNSA 07-29-2025
- GDV 01-01-0001
- Dividend Yield
- KNSA N/A
- GDV 5.81%
- EPS Growth
- KNSA N/A
- GDV N/A
- EPS
- KNSA N/A
- GDV N/A
- Revenue
- KNSA $481,166,000.00
- GDV N/A
- Revenue This Year
- KNSA $37.21
- GDV N/A
- Revenue Next Year
- KNSA $5.32
- GDV N/A
- P/E Ratio
- KNSA N/A
- GDV N/A
- Revenue Growth
- KNSA 59.45
- GDV N/A
- 52 Week Low
- KNSA $17.82
- GDV $18.04
- 52 Week High
- KNSA $30.69
- GDV $23.00
- Technical
- Relative Strength Index (RSI)
- KNSA 43.14
- GDV 60.42
- Support Level
- KNSA $28.19
- GDV $26.01
- Resistance Level
- KNSA $29.58
- GDV $26.47
- Average True Range (ATR)
- KNSA 0.93
- GDV 0.25
- MACD
- KNSA -0.13
- GDV -0.07
- Stochastic Oscillator
- KNSA 3.15
- GDV 48.00
About KNSA Kiniksa Pharmaceuticals Ltd.
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
About GDV Gabelli Dividend & Income Trust of Beneficial Interest
Gabelli Dividend & Income Trust operates as a diversified closed-end management investment company. The fund's investment objective is to provide a high level of total return on its assets with an emphasis on dividends and income. To achieve its objective, the fund may invest its assets in dividend-paying securities or other income-producing securities. The fund invests in various sectors, in which Financial Services, Food and Beverage, Health Care, Consumer Products, Electronics, and Computer Software & Services and others.